Related Experiment Video
Updated: Sep 15, 2025

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
A roadmap for T cell receptor-peptide-bound major histocompatibility complex binding prediction by machine learning:
Furong Qi1, Qiang Huang1, Yao Xuan1
1Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen 518112, Guangdong Province, China.
Identifying antigen-specific T cell receptors (TCRs) is crucial for cancer and infectious disease therapies. This review explores machine learning for TCR-pMHC prediction, offering a roadmap for improved accuracy in T-cell based interventions.
Area of Science:
- Immunology
- Computational Biology
- Bioinformatics
Background:
- Cytotoxic T lymphocytes (CTLs) are vital for fighting cancer and infections.
- T cell receptors (TCRs) mediate CTL activation by recognizing peptide-bound MHC (pMHC).
- Identifying antigen-specific CTLs and their TCRs is key for T-cell based therapies but is experimentally demanding.
Purpose of the Study:
- To review the biological basis of TCR-pMHC binding.
- To compare state-of-the-art machine learning algorithms for TCR-pMHC prediction.
- To propose a roadmap for advancing TCR-pMHC prediction accuracy.
Main Methods:
- Literature review of TCR-pMHC binding mechanisms.
- Comparative analysis of machine learning algorithms for TCR-pMHC prediction.
- Identification of discrepancies in current machine learning methods for specific diseases.
Main Results:
- Machine learning for TCR-pMHC prediction is gaining traction with single-cell technology advancements.
- Existing machine learning methods show limitations under specific disease conditions.
- A roadmap is proposed to enhance TCR-pMHC prediction by improving data, models, and application contexts.
Conclusions:
- Accurate TCR-pMHC prediction is essential for developing effective T-cell based vaccines and therapies.
- Addressing data quality, encoding, model training, and application context is crucial for progress.
- This review provides a framework to guide future research in TCR-pMHC prediction.
More Related Videos
08:27Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology
Published on: March 24, 2015
09:32Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
Published on: October 15, 2021
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...